The limited availability of liver donors and recent progress in cell therapy technologies has centered interest on cell transplantation as a therapeutic alternative to orthotopic liver transplant for restoring liver function. Following transplant by intraportal perfusion, the main obstacle to cell integration in the parenchyma is the endothelial barrier. Transplanted cells form emboli in the portal branches, inducing ischemia and reperfusion injury, which cause disruption of endothelial impermeability and activate the immune system. Approximately 95% of transplanted cells fail to implant and die within hours by anoikis or are destroyed by the host immune system. Intravascular perfusion of Bordetella pertussis toxin (PTx) blocks endothelial G i proteins and acts as a reversible inducer of actin cytoskeleton reorganization, leading to interruption of cell confluence in vitro and increased vascular permeability in vivo. PTx treatment of the murine portal vascular tree 2 h before intraportal perfusion of embryonic stem cells facilitated rapid cell engraftment. By 2 h postperfusion, the number of implanted cells in treated mice was more than fivefold greater than in untreated controls, a difference that was maintained to at least 30 days posttransplant. We conclude that prior to cell transplant, PTx blockade of the G i protein pathway in liver endothelium promotes rapid, efficient cell implantation in liver parenchyma, and blocks chemokine receptor signaling, an essential step in early activation of the immune system.
INTRODUCTION
to be integrated (40). Among the advantages of cell transplant compared to orthotopic liver transplant are the reduction in surgical complexity, rapid patient recovery, The best therapeutic alternative in severe liver failure, both acute and chronic, is currently an orthotopic liver lower costs, and that, at difference from the whole organ, cells can be cryopreserved for use in emergency transplant (33) . Donor availability nonetheless falls far short of the increasing demand, whereas the number of situations such as fulminant hepatitis (57, 58) . In murine models of hepatocyte transplant, good liver potential donors remains stable, resulting in delays and increased mortality of waiting list patients (1, 2) . Limited repopulation ratios can be obtained, with restoration of organ function (5, 43, 61) . These results have not been organ availability and recent developments in cell therapy technology have focused interest on cell transplant reproduced satisfactorily in humans (50, 57) , although partial improvement has been achieved in patients with technology as a therapeutic alternative for restoring liver mass and function (57). The special vascular structure metabolic disorders, complete correction of disease has yet to be reported (9, 15, 25, 39, 47, 50) . The principal con-of the liver makes this organ an excellent candidate for cell transplant. As liver sinusoids (capillaries) lack a straints to the introduction of cell transplant in clinical practice are a shortage of appropriate cells for transplant basement membrane and an intraportal cell perfusion system, endothelial cells are the only barrier between the and their limited implantation efficiency (12). Major advances have been made in optimizing protocols to perfused cells and the parenchyma into which they are 1384 ALFARO ET AL. obtain, transport, store, and perfuse cells (44, 58) , but gelatin-coated petri dishes in EC medium. HUVEC phenotype was determined by fluorescence microscopy unsatisfactory implantation results limit overall transplant efficiency (63) .
using fluorescein isothiocyanate (FITC)-labeled Ulex europaeus lectin (Sigma) and FITC-anti-CD31 (Invitrogen). After intraportal hepatocyte transplant, approximately 95% of transplanted cells die within the first 24 h by Purity of EC in cultures was always ≥ 98%. The phenotype of mouse liver endothelial cells was determined by anoikis, a form of apoptosis triggered by lack of survival signals induced by adhesion molecule binding to the fluorescence microscopy using FITC-Griffonia simplicifolia lectin (Sigma) (6, 38) ; purity of these cells in cul-extracellular matrix (48, 56) , or by cell destruction by the host immune system (23). Low cell transplant efficiency ture was always ≥ 95%. For intracellular calcium evaluation, HUVECs were is not unique to hepatocytes, but is also observed in other human cell transplant models (30) . Conditioning cultured on gelatin-coated coverslip chambers (Nunc, Roskilde, Denmark) for 24 h before treatment (1 h) with treatments that enhance cell implant have shown promising results in rodent models (35) . Such therapies 0.5 µg/ml PTx in culture medium. Cells were then washed three times, new medium added, and incubated increase vascular permeability and allow transplanted cells to move from the circulation to the perisinusoidal (30 min, 37°C). Medium was removed and cells treated (20 min) with 5 µM Calcium Green1 (Invitrogen) in space (space of Disse) and integrate into the tissue (34) . Most of these implantation enhancers nonetheless have PBS; cells were washed twice, new medium added, and incubated (37°C, 5% CO 2 ) until use in experiments limited usefulness, as they are toxic or slow to take effect (28, 29, 63) . (30-90 min) . Experiments were performed on a 37°C chamber coupled to a Radiance 2000 MP confocal/ We previously reported an in vitro method for evaluating potential engraftment enhancers, based on their multiphoton microscopy system (Bio-Rad, Hercules, CA). For embryonic stem (ES) cells, we used the B8-6C3 ability to disrupt endothelial cell adhesion. In an in vivo model, this would allow an increase in vascular perme-clone (A. Serrano and M. Torres, unpublished data) obtained by gene trapping (59) from R1 murine ES cells; ability sufficient to permit transplanted cells to pass from the circulation to the perisinusoidal space (3) .
ES cells were cultured as described previously (59) . In heterozygosis, these cells express a mutated variant of Using this approach, we identified B. pertussis toxin (PTx) as a possible potentiator of cell transplant. PTx is the alkaline ceramidase gene (Acer3). The mutation eliminates the C-terminal half of the Acer-3 protein secreted by the bacterium during infection and acts by catalyzing ADP ribosylation of G i proteins, which pre-(from amino acid 148 to the end) and replaces it with a DNA linker encoding 13 amino acids and cDNA encod-vents G i protein interaction with cell membrane receptors and interferes with intracellular communication ing amino acids 22 to 510 of human placental alkaline phosphatase (hPAP). Acer-3 mRNA is expressed ubiqui- (27) . Among other effects, inactivation of G i proteins block signaling through chemokine, histamine, and vaso-tously, with highest levels in placenta and liver (37) ; the resulting protein, Acer3-hPAP, shows the tissue and active amine receptors involved in regulating initiation of the inflammatory response and vasoregulation (10) . subcellular expression pattern of Acer-3 and enzyme activity of hPAP. Overexpression of hPAP in ES cells MATERIALS AND METHODS has no deleterious effects; transgenic mice ubiquitously Cells and Cell Culture expressing hPAP as a reporter show no developmental or viability defects (55) . Human umbilical vein endothelial cells (HUVECs) were isolated from umbilical cord by incubating vessel PTx Treatment of Confluent Cultures lumen with collagenase H (0.5 mg/ml; Sigma-Aldrich, St. Louis, MO) in 199 medium, as described previously Medium was replaced with fresh medium alone (negative control) or containing PTx (0.1 µg/ml; Sigma). (54), and cultured on 0.1% gelatin-coated (Sigma) plasticware in endothelial cell (EC) medium [199 medium Cultures were fixed at distinct intervals and the cell-free culture surface quantified by image analysis. To evalu-with 10 mM HEPES, 20% fetal calf serum (both from Invitrogen, Carlsbad, CA), 100 µg/ml heparin, and 100 ate recovery of cytoskeletal reorganization after PTx treatment, HUVECs were seeded in six-well dishes µg/ml endothelial cell growth supplement (both from Sigma)] (54). Institutional and national guidelines for (triplicates for each condition). Confluent cultures were PTx treated as above (1 h), medium removed, cells obtaining and manipulating human biological derivatives were followed and protocols were approved by the washed three times with medium 199, and new complete medium added. For controls, PTx was maintained in cul-institutional review board of the Hospital 12 de Octubre.
Mouse liver endothelial cells were obtained by colla-ture. At 1, 3, 6, 9, and 24 h after initiation of treatment, cultures were fixed (4% formaldehyde) and cell surface genase digestion of liver, purified on an Optiprep gradient (both from Sigma) (14,20), and cultured on 0.1% (µm 2 ) quantified by image analysis.
Stem Cell Endothelium Adhesion Assay
ES cells have strong AP activity (51), much higher than in hepatocytes, and can be distinguished from other ES cell adhesion to a PTx-treated confluent EC cell types by brief treatment (5 min) with nitro blue tetmonolayer was tested as described previously (3) and razolium (BCIP/NBT tablets, Roche, Basel, Switzerthe relative number of adhered ES cells was quantified land) and 0.1 mM levamisole (Sigma) to inactivate liver by determining alkaline phosphatase (AP) activity using AP (49). Implantation was evaluated in three 100µm the substrate p-nitrophenyl phosphate after 90-min inculiver sections per mouse. Three images were captured bation (3).
for each section in an Olympus IX71 inverted microscope with a Nikon DXM 1200 digital camera; images Microscopy and Image Processing and Analysis were analyzed and quantified with ImageTool (UTHSC, Cell cultures were fixed with 4% formaldehyde in San Antonio, TX), Adobe Photoshop, and Microsoft PBS. HUVECs were stained with FITC-labeled U. euro-Excel. We quantified the percentage of the section surpaeus lectin (10 µg/ml, 30 min) in PBS Ca-Mg (suppleface showing strong AP activity and determined cell mented with 1 mM each Ca 2+ and Mg 2+ ) and washed implantation rate after 2 h in each mouse as the mean three times with the same buffer (for all stainings); percentage of the AP-positive surface in the nine mouse endothelial cells were stained with FITC-G. simimages. As cells were dispersed throughout the tissue at plicifolia lectin (10 µg/ml) in PBS Ca-Mg. For phalloi-7 and 30 days posttransplant, we evaluated long-term din staining, fixed cells were permeabilized with PBS-0.1% implantation by counting the number of cells in each Triton X-100 (5 min), and stained with Alexa-488 phalimage and adjusting cell number to tissue volume. loidin (5 U/ml, 30 min; Invitrogen).
For confocal microscopy of cytoskeleton and of intra-Mice cellular calcium, we used an IX70 inverted microscope Cell transplant assays were performed using male with a 60 PlanApo NA 1.4 objective (Olympus, Tokyo, C57BL/6J mice (Jackson Laboratories, Bar Harbor, Japan), coupled to a Radiance 2000 MP microscope ME). All experimental protocols were approved by the (Bio-Rad). Excitation light was 488 nm (argon laser) Hospital Universitario 12 de Octubre Laboratory Animal and images were collected with a 510-560 nm emission Care and Use Committee and complied with national filter. Intracellular calcium was measured in 30 timeand European Union guidelines. lapse images captured every 3 s, beginning at 10 s from addition of chemokine (C-C motif) ligand 2 (CCL2;
Antibodies PeproTech, Rocky Hill, NJ; 5 nM final concentration).
For immunofluorescence of liver sections, we used Relative fluorescence intensity was quantified with monoclonal mouse anti-hPAP (clone 8B6, Sigma) and ImageJ software.
rat anti-mouse CD105 (BioLegend, San Diego, CA) To evaluate the cultured cell area, cultures were fixed antibodies. Secondary antibodies were Cy2-conjugated and permeabilized as above, stained with 0.5% Evans goat anti-mouse and Cy3-goat anti-rat IgG (both from blue in PBS (20 min), and viewed on an Olympus IX71 Jackson ImmunoResearch, West Grove, PA), used fluorescence inverted microscope using Texas red exciaccording to manufacturer's recommendations. tation/emission filters. Five random images were taken for each condition and culture, to allow quantification Drugs of at least 400 cells per point.
Following anesthesia with inhaled isoflurane (Forane; For confocal microscopy of tissue sections, we used Abbott, Berkshire, UK), 12 mice received intrasplenic an LSM510 microscope with 10 and 20 PlanApo objecinjections of 100 µl PTx in PBS (5 µg/kg body weight) tives (Zeiss, Jena, Germany); Cy2 fluorescence was coland 12 received PBS alone. After 2 h, mice were reaneslected between 500 and 550 nm after excitation with the thetized and received a slow intraportal injection of 200 488-nm line of an argon laser. Cy3 fluorescence was µl DMEM containing ES cells (2 × 10 6 /ml), the abdomicollected between 570 and 683 nm after excitation with nal cavity was sutured, and mice were reanimated. For a diode laser (561 nm).
short-term evaluation, mice were sacrificed after 2 h, and livers were removed and fixed as above. Six addi-Histology and Histochemistry tional mice (three control, three PTx treated) were sacrificed at 24 h posttransplant and another 12 at 7 and 30 Mice were sacrificed, livers were extracted immediately and perfused intraportally twice with 20 ml PBS, days posttransplant (three control, three PTx treated each). Mice evaluated at 7 and 30 days were treated 24 fixed in 50 ml 4% formaldehyde in PBS (2 h, 4°C), then washed three times with 100 ml PBS (4°C). Sections h posttransplant with an intraperitoneal (IP) bolus of prednisone (2 mg/kg, single dose) and with tacrolimus (50 or 100 µm) were prepared for histology using a VT1200S vibratome (Leica, Mannheim, Germany).
(2 mg/kg/day, IP) until 1 day before sacrifice.
Visualization of PTx Effect on Hepatic Blood Vessels PTx Treatment of Endothelial Cells Blocks Signaling Through G i Proteins PTx or PBS was administered by intraportal injection
To show that PTx blocks G i proteins in endothelial and mice were sacrificed after 2 h. Livers were procells, we studied signaling through CCR2, which is cessed and sections (50 µm) stained with FITC-G. simexpressed in endothelial cells (52), is G i protein-coupled plicifolia lectin as above. For each photograph, seven (41) . Signaling through CCR2 includes calcium mobiliimages were taken using bright field illumination with zation, which is inhibited by PTx treatment (45) . We the same x-y coordinates, separated by 7 µm on the z studied intracellular calcium fluctuation by quantifying axis. Photographs stacked using ImageJ were decongreen fluorescence on Calcium Green-1-loaded HUVECs volved with Huygens Essential (Scientific Volume by time-lapse fluorescence microscopy. In a series of 30 Imaging, Hilversum, The Netherlands), followed by 3D images captured every 3 s beginning at 10 s post-CCL2 reconstruction and projection using Imaris 3.0 (Bitplane, stimulation of a PTx-treated endothelial cell, calcium Zurich, Switzerland). levels did not vary and were similar throughout the Statistical Analysis series (Fig. 2C) ; in untreated cells, we observed calcium Data are presented as mean ± SEM. Significance of variations in response to CCL2 (Fig. 2D ). In four addidifferences was analyzed by Student's t-test using tional experiments, calcium fluctuations were graphed STATA v.10.0 (StataCorp LP, College Station, TX). A for PTx-treated HUVECs and untreated control cells in value of p < 0.05 was considered significant.
response to CCL2 ( Fig. 2E ).
In Vitro PTx Pretreatment of Confluent Endothelium

RESULTS
Facilitates ES Cell Adhesion PTx Reversibly Disrupts Endothelial Cell Confluence
In an in vitro cell transplant simulation system, loss PTx treatment produced cell refolding, with cytoof continuity in a confluent culture of PTx-treated endoplasmic contraction, disruption of intercellular junctions, thelial cells creates an acellular surface that permits and loss of confluence in the cell cultures. We observed adhesion of other cell types (4) . When seeded onto a the formation of numerous intercellular gaps, leading to culture of HUVECs pretreated with PTx for 90 min, ES a reduction in the culture area covered by cells; cell-free cells adhered rapidly to HUVEC-free surfaces, and areas were visible from 30 min post-PTx treatment ( Fig. remained attached 1 h after seeding, following medium 1A). In confluent cell culture conditions, HUVEC removal and washing (Fig. 3A) . When seeded onto a adhered strongly to the plastic substrate and to adjacent confluent HUVEC culture (which simulates a blood vescells, and cultures showed a cobblestone appearance sel wall), mouse ES cells did not adhere and could be ( Fig. 1B) . A bright field microscopy time-lapse movie removed from culture 1 h after seeding (Fig. 3B ). Adheshowing 8 h of a confluent HUVEC culture treated with sion to the cell-free surface was rapid; by 15 min, 50% 0.1 µg/ml PTx can be downloaded from http://www. of seeded cells had adhered to the surface (Fig. 3C ). imas12.es/doc/PTx-HUVEC.avi When PTx was present continuously in culture, the PTx Induces Loss of Confluence in Liver Endothelial acellular surface (Fig. 1C ) and the decrease in the mean Cells Both In Vitro and In Vivo area covered by a single cell ( Fig. 1D, gray bars) were Following PTx treatment, liver endothelial cells maximal at 3-4 h posttreatment and persisted for 24 h showed refolding that left cell-free substrate areas, simiwithout affecting cell viability (98% as measured by trylar to HUVECs (Fig. 4A ). Endothelial cells derived from pan blue staining, not shown). PTx treatment for 1 h murine liver sinusoids and cultured to confluence had a followed by washing of cells led to a decline in the mean cobblestone appearance, similar to that of HUVECs area covered by a single cell, which was maximal at (Fig. 4B ). PTx also acted on the hepatic vascular tree approximately 3-4 h, began to recover after 6 h, and endothelium in vivo. At 2 h after slow intraportal perfureturned to original values at 24 h (Fig. 1D, white bars) . sion of PTx, FITC-G. simplicifolia lectin staining of the vascular tree showed cytoplasmic refolding similar to Cell Refolding Is Due to Reorganization that observed in cell cultures; the appearance of the of the Actin Cytoskeleton endothelium was discontinuous and blurred ( Fig. 4C , E) PTx treatment of confluent HUVEC cultures induces whereas hepatic vessels of PBS-perfused mice showed cytoplasmic refolding, with reorganization of actin filaa continuous endothelium (Fig. 4D, F) . ments in the cytoskeleton (18). In treated cells, stress PTx Pretreatment of Mouse Liver Endothelium fibers disappeared and actin filaments concentrated Promotes Establishment of Transplanted ES Cells around the plasma membrane ( Fig. 2A) , whereas they were organized as parallel stress fibers in untreated cells
We transplanted ES cells by intraportal perfusion into livers of mice treated intrasplenically 2 h pretransplant (Fig. 2B) . with PBS or with PTx. Mice were sacrificed after 2 h mice and 1.09 ± 0.73% in untreated controls (p < 0.001) (Fig. 5C ). and the degree of ES cell implantation in parenchyma was evaluated by detection of ES cell AP activity. PTx-ES cells transplanted in the liver were restricted to the periphery of the lobule nearest the portal vein pretreated mice showed strong ES cell AP activity in larger areas of liver sections (Fig. 5A ) than did control branches, with some ES cells within the sinusoids, but not in centrilobular veins or hepatic vein branches. In mice (Fig. 5B) . In 100-µm tissue sections, we observed a cell implantation rate of 6.36 ± 1.74% in PTx-treated mice evaluated 24 h posttransplant, implanted cells remained within the liver (Fig. 5D ). Differences in AP-6E). These differences between treated and untreated mice were very similar to those observed at 2 h posttransplant. stained ES cells between control and PTx-treated mice were similar to those observed at 2 h (not shown), DISCUSSION although transplanted ES cells were perivascular at 2 h and were found within the lobule at 24 h posttransplant To be integrated into the parenchyma, ES cells transplanted by intraportal catheter must cross the endothelial (Fig. 5D) .
barrier, the main obstacle to their implantation (34) .
Long-Term Cell Engraftment
Here we show that PTx pretreatment of the portal vascular tree enhances early liver implant of intraportally per-Transplanted cells can be detected in liver parenchyma after 30 days by visualization of AP using NBT/ fused ES cells. PTx-treated endothelial cells undergo cytoplasmic folding and intercellular junctions are BCIP as substrate. Although endogenous AP expression is lost in differentiating ES cells, hPAP is fused to Acer-destabilized; vascular permeability increases due to G i blockage-mediated activation of p38 and p42/p44 mito-3 under the control of the murine promoter, leading to generalized expression, particularly in liver (37) . Sub-gen-activated protein (MAP) kinases, which induce restructuring of the actin cytoskeleton (17,18). cellular Acer3-hPAP expression nonetheless differs from AP expression in cultured ES cells, as AP activity
As the liver capillary (liver sinusoid) has no basement membrane (62), PTx-induced endothelial cyto-is found in Golgi and at one cell pole in transplanted ES cells. A figure showing Acer3-hPAP expression can be plasmic reorganization has particular impact in liver, achieving greater permeability than in endothelia with a obtained at http://www.imas12.es/doc/Alfaro-Sup1.pdf At 30 days posttransplant, cells in PTx-treated mice basement membrane. Although the permeabilizing effect of PTx has been described previously (8) , our data show showed generalized distribution throughout the liver parenchyma (Fig. 6A) , which was evident by 24 h and that this increase can facilitate liver cell implantation by intravascular infusion, and suggest a role for PTx as a at 7 days after transplant (not shown). Transplanted cells in untreated controls were less numerous and were engraftment enhancer. The temporal dynamics of PTx allows more rapid, efficient implantation than strategies observed mainly around large vessels, with few cells in the parenchyma (Fig. 6B) ; in controls, distribution at 30 based on cytotoxic treatments such as cyclophosphamide or irradiation (22, 28, 34, 64) . The rapid effect of days was similar to that observed at 2 and 24 h and 7 days posttransplant (not shown).
PTx facilitates survival of the infused cells. PTx pretreatment of liver endothelium does not Transplanted cells in PTx-treated mice were also visualized by confocal microscopy using monoclonal anti-appear to affect the migratory or implantation capacity of the transplanted cells. Although PTx blockade of hPAP followed by a Cy2-labeled secondary antibody. Lobule structure was detected by vessel staining with chemokine receptor signaling (42) inhibits cell migratory ability by 50% at 2 h posttreatment (7) , the brief antibody to the endothelial cell marker CD105 (21) followed by a Cy3-secondary antibody, and by autofluores-period (seconds) between perfusion of transplanted cells and their entry into the capillary terminals is insufficient cence (Fig. 6C, D) . AP retained in cytoplasm can be visualized with anti-hPAP, but is enzymatically inactive for blockade. Mechanisms for cell integration into the hepatic (36,53), whereas histochemical analysis identifies only active AP, explaining the difference in subcellular distri-parenchyma in the classical intraportal hepatocyte transplant model have only begun to be understood. Perfused bution patterns. The number of transplanted cells in recipient liver/mm 3 of parenchyma is significantly higher cells are not integrated immediately, but embolize and remain trapped in the liver sinusoid, causing portal (p < 0.05) in PTx-pretreated mice at 7 days (166 ± 52 cells/mm 3 ) and 30 days (129 ± 28) after transplant com-hypertension and ischemia (12). This leads to the death of many transplanted cells by oxidative stress and pared to controls (7 days, 25 ± 7; 30 days, 27 ± 4) ( apoptosis due to lack of adhesion (66); dead cells are survival of transplanted cells (26,65). In its original context of B. pertussis infection, PTx inhibits early inflam-eliminated by Kupffer cells and granulocytes (26). Ischemia reperfusion injury induces the release of proin-matory response in two ways: it blocks chemokine production by inflamed tissues and, by preventing sig-flammatory chemokines and cytokines that increase vascular permeability, allowing surviving cells to naling through chemokine receptors, it impedes mobilization/entry of new immune cells (42) . In addition to translocate through the sinusoidal endothelium and to integrate into the parenchyma (31) .
blocking early mechanisms of destruction, PTx aids transplanted cell survival by reducing the probability of Although this activation of the inflammatory response in early stages of transplant promotes the inte-anoikis, as it permits rapid cell extravasation and implantation (23). PTx activity is thus of interest, as it gration of surviving cells, it is counterproductive in the medium and long term, as inflammatory processes can improves vascular permeability and limits the early immune response to the transplanted cells. eliminate the transplanted cells (24,26,61,65). Control of immune system activity is essential in the early stages
We used ES cells as donor cells for in vivo transplant experiments, as they are easily available from culture of cell transplant, since functional blockade at the outset of the response, particularly of Kupffer cells, improves (59) , are an appropriate choice for cell therapy because of their potential to differentiate into a variety of lin-The number of cells transplanted to each mouse was relatively small, to ensure identification of individual eages (16), have been used effectively in transplant experiments in liver (46), can differentiate into hepato-cells and avoid embolus formation in blood vessels, which would complicate assessment of implantation as cytes in vitro and in vivo (11, 13) , and show strong AP expression in the plasma membrane, allowing them to due to the effect of PTx or to ischemia reperfusion mechanisms secondary to embolization. To facilitate be distinguished from other cell types in histological sections (19) . To avoid dual insult to the portal vein, their detection, we evaluated the ES cells in thick (50-100 µm) histological sections. Implantation index values PTx or control pretreatment was administered by intrasplenic injection, as the spleen vascular supply allows from histological section areas with AP activity correspond to a much larger volume than in standard histological rapid passage from spleen sinuses to the liver. sections; thicker sections showed more homogeneous pathways yields a similar permeabilization effect with improved clinical applicability. ES cell distribution with less variability, permitting more accurate comparison of treated and control mice.
Our study focused on early stages of transplant, due to the importance of rapid implantation to improve sur-In mice, a single PTx dose has a transient effect on vascular permeability, with recovery at 24 h (32) .
vival of transplanted cells (48) . We achieved a higher degree of initial cell implant; further tests will show Although PTx is a bacterial toxin, it showed minimum toxicity in pharmacological studies of histamine sensi-whether this translates to more rapid functional recovery and to an increase in the liver repopulation capacity of tization when used within the activity range (10-72 µg/ kg) (60) . The dose used here (5 µg/kg) is well below transplanted cells, which could allow long-term function maintenance. that which induces cardiovascular effects (20 µg/kg) (32) . Additional studies are needed to establish the CONCLUSION minimum effective dose to reduce possible adverse effects, and other potentially less toxic G i inhibitors Prior to cell transplant by intraportal perfusion, PTx treatment to block the G i protein pathway in liver endo-should be tested. It should also be determined whether interference at other points in G i protein signaling thelium promotes rapid, efficient cell implantation in 
